Monopar Therapeutics Inc
(MNPR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -4,225 | -3,228 | -16,555 | N/A |
| Other Working Capital | 196 | 22 | 121 | N/A |
| Other Operating Activity | 1,011 | 525 | 13,807 | 0 |
| Operating Cash Flow | $-3,018 | $-2,681 | $-2,628 | $N/A |
| Cash Flows From Investing Activities | ||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 10,332 | N/A | 4,706 | N/A |
| Other Financing Activity | -985 | -206 | 4,831 | 0 |
| Financing Cash Flow | $9,347 | $-206 | $9,536 | $N/A |
| Exchange Rate Effect | -9 | -2 | N/A | N/A |
| Beginning Cash Position | 6,893 | 9,782 | 2,873 | N/A |
| End Cash Position | 13,214 | 6,893 | 9,782 | N/A |
| Net Cash Flow | $6,321 | $-2,889 | $6,909 | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -3,018 | -2,681 | -2,628 | N/A |
| Free Cash Flow | -3,018 | -2,681 | -2,628 | 0 |